🔎 Trials Near Me

Dachaigh › Galar cealla corraich › Alabama › Birmingham

Sgrùdaidhean clionaigeach Galar cealla corraich ann an Birmingham, AL

Tha 14 sgrùdaidhean airson Galar cealla corraich a’ lorg phàirtichean aig làraichean ann agus timcheall air Birmingham (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

A’ fastadhÌre 1
  • University of Alabama at Birmingham, Birmingham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07187973

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

A’ fastadhÌre 3
  • Uni of Alabama at Birmingham, Birmingham
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT06612268

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

A’ fastadhÌre 1/2Fàilte do shaor-thoilich fhallain
  • University of Alabama Birmingham, Birmingham
Aoisean 12 gu 55 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06546670

SCD Stem Cell Mobilization and Apheresis Using Motixafortide

A’ fastadhÌre 1
  • University of Alabama at Birmingham, Birmingham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06442761

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

A’ fastadhÌre 1/2Fàilte do shaor-thoilich fhallain
  • University of Alabama at Birmingham, Birmingham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT06481306

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

A’ fastadhÌre 3
  • University of Alabama at Birmingham- Site Number : 8400003, Birmingham
Aoisean 10 gu 65 · Gach gnè · Air ùrachadh 29 Iuch 2026 · NCT06975865

Early Life Exposures Among Children With Sickle Cell Disease

A’ fastadh
  • University of Alabama at Birmingham, Birmingham
Aoisean 18 gu 50 · Banairean · Air ùrachadh 15 Iuch 2026 · NCT05377372

Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study

A’ fastadhÌre 4
  • University Of Alabama, Birmingham
6 Months – 100 Years · Gach gnè · Air ùrachadh 8 Ògmh 2026 · NCT04657822

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

A’ fastadhSgrùdadh amharc
  • Children's of Alabama (MRD-HCT), Birmingham
  • Children's of Alabama (NT-DMT), Birmingham
Aoisean 3 gu 20 · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT06941389

Cognitive Remediation Intervention to Prepare for Transition of Care

A’ fastadhÌre 2
  • University of Alabama at Birmingham, Birmingham
Aoisean 10 gu 18 · Gach gnè · Air ùrachadh 27 Gearr 2026 · NCT05336201

A Long-term Follow-up Study in Patients Who Received BEAM-101

A’ fastadhSgrùdadh amharc
  • University of Alabama at Birmingham, Birmingham
Aoisean 14 gu 37 · Gach gnè · Air ùrachadh 28 Faoi 2026 · NCT07373639

HPC Offered for PRESERVE Expansion

A’ fastadhSgrùdadh amharc
  • University of Alabama, Birmingham, Birmingham
Aoisean 12 gu 80 · Gach gnè · Air ùrachadh 28 Lùna 2025 · NCT07145411

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

A’ fastadhSgrùdadh amharc
  • University of Alabama, Birmingham (UAB), Birmingham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Ògmh 2025 · NCT06385886

Sgrùdaidhean Galar cealla corraich ann am bailtean eile

Sgrùdaidhean eile ann an Birmingham

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.